510(k) Report

510(k) · Cleared

Cleared

Novabone-Bioactive Synthetic Graft

K052494510(k) TraditionalCleared Nov 3, 200552-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Novabone Products, LLC · MQV Filler, Bone Void, Calcium Compound

Cleared on Nov 3, 2005 as substantially equivalent to K021336 (Novabone Products, LLC, 2002) after a 52-day review. Its family tree reaches back 3 generations to 1996. 123 later devices descend from it.

Decided
Nov 3, 2005
Review
52 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K960978 (1996). 4 ancestors in all. 123 later devices descend from it, 5 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1997: 1 other ancestor2008: 5 descendants cleared2007: 6 descendants cleared2014: 8 descendants cleared2006: 1 descendant cleared2012: 2 descendants cleared2011: 9 descendants cleared2019: 4 descendants cleared2009: 6 descendants cleared2010: 7 descendants cleared2016: 3 descendants cleared2017: 5 descendants cleared2013: 3 descendants cleared2015: 7 descendants cleared2024: 12 descendants cleared2026: 8 descendants cleared2020: 2 descendants cleared2021: 2 descendants cleared2023: 10 descendants cleared2022: 5 descendants cleared2018: 5 descendants cleared2025: 13 descendants clearedK960978 · Wright Plaster of Paris Pellets (Subject to Revision) · Wrightmedicaltechnologyinc · 1996K980817 · Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05, 5RG10, 5RG15, 5G15L, 5RG20, 5RG30, 5RG30L · Interpore Intl. · 1998K021336 · Novabone-Resorbable Bone Graft Substitute · Novabone Products, LLC · 20021995200020052010201520202025
Other ancestors, by generationDescendants, by generation 2 generations back: 1 other ancestor 1 generation forward: 5 descendants2 generations forward: 26 descendants3 generations forward: 29 descendants4 generations forward: 34 descendants5 generations forward: 20 descendants6 generations forward: 7 descendants7 generations forward: 2 descendants K021336 · Novabone-Resorbable Bone Graft Substitute · Novabone Products, LLC · 2002K980817 · Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05, 5RG10, 5RG15, 5G15L, 5RG20, 5RG30, 5RG30L · Interpore Intl. · 1998K960978 · Wright Plaster of Paris Pellets (Subject to Revision) · Wrightmedicaltechnologyinc · 19960+5
  1. Root · 3 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
  2. 2 generations backK980817 Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model…Interpore Intl. · 1998
  3. 1 generation backK021336 Novabone-Resorbable Bone Graft SubstituteNovabone Products, LLC · 2002
  4. This deviceK052494 Novabone-Bioactive Synthetic GraftNovabone Products, LLC · 2005
  5. Descendant · cites it directly · 71 of its ownK080009 Novabone Putty- Bioactive Synthetic GraftNovabone Products, LLC · 2008
  6. Descendant · 2 generations on · 59 of its ownK082672 Novabone Putty-Bioactive Synthetic Bone GraftNovabone Products, LLC · 2008
  7. Descendant · cites it directly · 51 of its ownK072184 Vitoss Bioactive Foam Bone Graft SubstituteOrthovita, Inc. · 2007
  8. Descendant · 2 generations on · 50 of its ownK081439 Vitoss Bioactive Foam Pack Bone Graft SubstituteOrthovita, Inc. · 2008
  9. Descendant · 2 generations on · 47 of its ownK101860 Novabone Putty- Bioactive Synthetic Bone GraftNovabone Products, LLC · 2010

Showing 5 of 123 descendants. See all descendants

Descendants cleared per year

2006: 12007: 62008: 52009: 62010: 72011: 92012: 22013: 32014: 82015: 72016: 32017: 52018: 52019: 42020: 22021: 22022: 52023: 102024: 122025: 132026: 8
2006high 13 (2025) · low 1 (2006)2026

Most influential descendants

Showing 5 of 123 · See all
  • K080009Novabone Putty- Bioactive Synthetic GraftNovabone Products, LLC · 2008 · cites it directly71descendants
  • K082672Novabone Putty-Bioactive Synthetic Bone GraftNovabone Products, LLC · 2008 · 2 generations on59descendants
  • K072184Vitoss Bioactive Foam Bone Graft SubstituteOrthovita, Inc. · 2007 · cites it directly51descendants
  • K081439Vitoss Bioactive Foam Pack Bone Graft SubstituteOrthovita, Inc. · 2008 · 2 generations on50descendants
  • K101860Novabone Putty- Bioactive Synthetic Bone GraftNovabone Products, LLC · 2010 · 2 generations on47descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K960978Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc1996—
−2K980817Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05…Interpore Intl.1998—
−1K021336Novabone-Resorbable Bone Graft SubstituteNovabone Products, LLC2002—
0 (this device)K052494Novabone-Bioactive Synthetic GraftNovabone Products, LLC2005—
+1K080009Novabone Putty- Bioactive Synthetic GraftNovabone Products, LLC2008—
+2K082672Novabone Putty-Bioactive Synthetic Bone GraftNovabone Products, LLC2008—
+1K072184Vitoss Bioactive Foam Bone Graft SubstituteOrthovita, Inc.2007—
+2K081439Vitoss Bioactive Foam Pack Bone Graft SubstituteOrthovita, Inc.2008—
+2K101860Novabone Putty- Bioactive Synthetic Bone GraftNovabone Products, LLC2010—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
200760
200850
200960
201070
201190
201220
201330
201480
201570
201630
201750
201850
201940
202020
202120
202250
2023100
2024120
2025130
202680
FIG. 1 — Lineage of K052494, 1996–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K021336Novabone-Resorbable Bone Graft Substitute
Summary page 1
…Classification Name: Unknown 3. Legally Marketed Predicate Device: Predicate #1: NovaBone - Resorbable Bone Graft Substitute [K021336] 4. Device Description NovaBone is a one-component resorbable bone void filler composed of a synthetic calcium phosp…
Novabone Products, LLC2002—

Also cleared against K021336: 12 other devices →

What descends from it? (123)

See all 123

5 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K080009Novabone Putty- Bioactive Synthetic GraftNovabone Products, LLC200871
K072184Vitoss Bioactive Foam Bone Graft SubstituteOrthovita, Inc.200751
K132805BG MorselsProsidyan, Inc.201433
K053387Perioglas Bone Graft ParticulateNovabone Products, LLC200613
K070998Inion BiorestoreInion OY20074

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 9 years and passes through 3 companies; a new generation was cleared every 3.3 years on median.
  • None of the 4 ancestors has a recall.
  • Of its descendants, K080009 (Novabone Products, LLC, 2008) has gone furthest, with 71 descendants of its own.
  • 12 other devices also cite its predicate K021336.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

NovaBone Resorbable Bone Graft Substitute is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. NovaBone is indicated to be gently packed into bony voids or gaps of the skeletal system (i.e. the extremities, spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced with bone during the healing process.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K052494: Novabone-Bioactive Synthetic Graft.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K052494

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026